| Year |
Title |
Altmetric |
| 2020
|
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes.
Frontiers in Genetics.
10.
2020
|
|
| 2020
|
SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly through the Modulation of cIAP2.
Anticancer Research.
40:9-26.
2020
|
|
| 2019
|
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer..
Cells.
8.
2019
|
|
| 2019
|
Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy.
International Journal of Molecular Sciences.
20.
2019
|
|
| 2019
|
Prenatal epigenetics diets play protective roles against environmental pollution.
Clinical Epigenetics.
11.
2019
|
|
| 2019
|
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology..
Cells.
8.
2019
|
|
| 2019
|
Collaborative molecular epidemiology study of metabolic dysregulation, DNA methylation, and breast cancer risk among Nigerian women: MEND study objectives and design.
Journal of Global Oncology.
2019.
2019
|
|
| 2019
|
Could epigenetics help explain racial disparities in chronic pain?.
Journal of Pain Research.
12:701-710.
2019
|
|
| 2019
|
Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells.
Cancers.
11.
2019
|
|
| 2018
|
The Role of Non-Coding RNAs and Isothiocyanates in Cancer.
Nahrung..
62.
2018
|
|
| 2018
|
Combinational proanthocyanidins and resveratrol synergistically inhibit human breast cancer cells and impact epigenetic–Mediating machinery.
International Journal of Molecular Sciences.
19.
2018
|
|
| 2018
|
Temporal efficacy of a sulforaphane-based broccoli sprout diet in prevention of breas cancer through modulation of epigenetic mechanisms.
Cancer Prevention Research.
11:451-464.
2018
|
|
| 2018
|
Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
Experimental Cell Research.
368:67-74.
2018
|
|
| 2018
|
The effects of combinatorial genistein and sulforaphane in breast tumor inhibition: Role in epigenetic regulation.
International Journal of Molecular Sciences.
19.
2018
|
|
| 2018
|
Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Journal of Cellular Biochemistry.
119:3326-3337.
2018
|
|
| 2018
|
Mechanisms for the inhibition of colon cancer cells by sulforaphane through epigenetic modulation of microRNA-21 and human telomerase reverse transcriptase (hTERT) down-regulation.
Current Cancer Drug Targets.
18:97-106.
2018
|
|
| 2018
|
Transforming cancer epigenetics using nutritive approaches and noncoding RNAs.
Current Cancer Drug Targets.
18:32-38.
2018
|
|
| 2017
|
Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
Scientific Reports.
7.
2017
|
|
| 2017
|
Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
PLoS ONE.
12.
2017
|
|
| 2017
|
Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.
Critical Reviews in Clinical Laboratory Sciences.
54:529-550.
2017
|
|
| 2017
|
The influence of an epigenetics diet on the cancer epigenome.
Epigenomics.
9:1153-1155.
2017
|
|
| 2017
|
A novel combination of withaferin A and sulforaphane inhibits epigenetic machinery, cellular viability and induces apoptosis of breast cancer cells.
International Journal of Molecular Sciences.
18.
2017
|
|
| 2017
|
Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells
2017
|
|
| 2016
|
Age-related epigenetic drift and phenotypic plasticity loss: Implications in prevention of age-related human diseases.
Epigenomics.
8:1637-1651.
2016
|
|
| 2016
|
Combinatorial epigenetic mechanisms and efficacy of early breast cancer inhibition by nutritive botanicals.
Epigenomics.
8:1019-1037.
2016
|
|
| 2016
|
Erratum: Erratum to “Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 cancer cells with PX-866 and Raloxifene” [Exp. Cell Res. 344 (2016) 95–102] (Experimental Cell Research (2016) 344 (95–102) (S0014482716300623) (10.1016/j.yexcr.2016.03.022)).
Experimental Cell Research.
345:255.
2016
|
|
| 2016
|
Combinatorial PX-866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF-7 Breast Cancer Cells.
Journal of Cellular Biochemistry.
117:1688-1696.
2016
|
|
| 2016
|
Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.
Experimental Cell Research.
344:95-102.
2016
|
|
| 2016
|
Regulation of the telomerase reverse transcriptase subunit through epigenetic mechanisms.
Frontiers in Genetics.
7.
2016
|
|
| 2016
|
A novel combinatorial epigenetic therapy using resveratrol and pterostilbene for restoring estrogen receptor-α (ERα) expression in ERα-negative breast cancer cells.
PLoS ONE.
11.
2016
|
|
| 2015
|
Epigenetic regulation of epidermal stem cell biomarkers and their role in wound healing.
International Journal of Molecular Sciences.
17.
2015
|
|
| 2015
|
Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases.
Clinical Epigenetics.
7.
2015
|
|
| 2015
|
Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
BMC Cancer.
15.
2015
|
|
| 2015
|
Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer.
Frontiers in Nutrition.
2.
2015
|
|
| 2015
|
Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.
Molecular and Cellular Endocrinology.
406:102-114.
2015
|
|
| 2015
|
The Epigenetic Impact of Cruciferous Vegetables on Cancer Prevention.
Current Pharmacology Reports.
1:46-51.
2015
|
|
| 2015
|
Epigenetic linkage of aging, cancer and nutrition.
Journal of Experimental Biology.
218:59-70.
2015
|
|
| 2015
|
Impact of epigenetic dietary components on cancer through histone modifications.
Current Medicinal Chemistry.
22:2051-2064.
2015
|
|
| 2014
|
Aging and energetics' 'Top 40' future research opportunities 2010-2013.
F1000Research.
3.
2014
|
|
| 2014
|
Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.
Experimental Cell Research.
324:40-53.
2014
|
|
| 2014
|
Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.
Journal of Cellular Physiology.
229:393-406.
2014
|
|
| 2014
|
Dietary epigenetics in cancer and aging.
Cancer Treatment and Research.
159:257-267.
2014
|
|
| 2014
|
Impact of epigenetic dietary compounds on transgenerational prevention of human diseases.
AAPS Journal.
16:27-36.
2014
|
|
| 2013
|
Medicinal chemistry of the epigenetic diet and caloric restriction.
Current Medicinal Chemistry.
20:4050-4059.
2013
|
|
| 2013
|
Genetics and epigenetics of lung cancer: Mechanisms and future perspectives.
Current Cancer Therapy Reviews.
9:97-110.
2013
|
|
| 2013
|
Real-time methylomic aberrations during initiation and progression of induced human mammary epithelial cell tumorigenesis.
Epigenomics.
5:155-165.
2013
|
|
| 2013
|
MicroRNAs: An emerging science in cancer epigenetics.
Journal of Clinical Bioinformatics.
3.
2013
|
|
| 2013
|
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Experimental Cell Research.
319:697-706.
2013
|
|
| 2013
|
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Molecular Cancer.
12.
2013
|
|
| 2013
|
Epigenetic Regulation of Multiple Tumor-Related Genes Leads to Suppression of Breast Tumorigenesis by Dietary Genistein.
PLoS ONE.
8.
2013
|
|
| 2013
|
Analysis of biomarkers of caloric restriction in aging cells.
Methods in Molecular Biology.
1048:19-29.
2013
|
|
| 2013
|
Cell senescence culturing methods.
Methods in Molecular Biology.
1048:1-10.
2013
|
|
| 2013
|
Enhancement of cisplatin-mediated apoptosis in ovarian cancer cells through potentiating G2/M arrest and p21 upregulation by combinatorial epigallocatechin gallate and sulforaphane.
Journal of Oncology.
2013
|
|
| 2012
|
Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
PLoS ONE.
7.
2012
|
|
| 2012
|
Regulation of the human catalytic subunit of telomerase (hTERT).
Gene.
498:135-146.
2012
|
|
| 2012
|
The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes.
Journal of Oncology.
2012
|
|
| 2012
|
Mitochondrial regulation of epigenetics and its role in human diseases.
Epigenetics.
7:326-334.
2012
|
|
| 2011
|
Epigenomics of ovarian cancer and its chemoprevention.
Frontiers in Genetics.
2.
2011
|
|
| 2011
|
Methylated-CpG Island recovery assay.
Methods in Molecular Biology.
791:125-133.
2011
|
|
| 2011
|
Advances in epigenetic technology.
Methods in Molecular Biology.
791:1-10.
2011
|
|
| 2011
|
Combined chromatin immunoprecipitation and bisulfite methylation sequencing analysis.
Methods in Molecular Biology.
791:239-251.
2011
|
|
| 2011
|
DNA methylation detection: Bisulfite genomic sequencing analysis.
Methods in Molecular Biology.
791:11-21.
2011
|
|
| 2011
|
Epigenetic regulation of caloric restriction in aging.
BMC Medicine.
9.
2011
|
|
| 2011
|
A novel prodrug of epigallocatechin-3-gallate: Differential epigenetic hTERT repression in human breast cancer cells.
Cancer Prevention Research.
4:1243-1254.
2011
|
|
| 2011
|
Epigenetic diet: Impact on the epigenome and cancer.
Epigenomics.
3:503-518.
2011
|
|
| 2011
|
Insufficient DNA methylation affects healthy aging and promotes age-related health problems.
Clinical Epigenetics.
2:349-360.
2011
|
|
| 2011
|
The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.
Clinical Epigenetics.
2:97-112.
2011
|
|
| 2011
|
Epigenetic regulation of Thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
American Journal of Respiratory Cell and Molecular Biology.
45:16-23.
2011
|
|
| 2011
|
Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.
Carcinogenesis.
32:597-604.
2011
|
|
| 2011
|
P16INK4A suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms.
PLoS ONE.
6.
2011
|
|
| 2011
|
2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells.
Journal of Proteome Research.
10:447-458.
2011
|
|
| 2010
|
Epigenetic targets of bioactive dietary components for cancer prevention and therapy.
Clinical Epigenetics.
1:101-116.
2010
|
|
| 2010
|
Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells.
Molecular Cancer.
9.
2010
|
|
| 2010
|
Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
PLoS ONE.
5.
2010
|
|
| 2010
|
Polyphenols and aging.
Current Aging Science.
3:34-42.
2010
|
|
| 2010
|
Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression.
Federation proceedings.
24:1442-1453.
2010
|
|
| 2010
|
Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.
Current Medicinal Chemistry.
17:2141-2151.
2010
|
|
| 2009
|
Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.
Anticancer Research.
29:4959-4964.
2009
|
|
| 2009
|
Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.
International Journal of Cancer.
125:286-296.
2009
|
|
| 2009
|
DNA methylation impacts on learning and memory in aging.
Neurobiology of Aging.
30:549-560.
2009
|
|
| 2009
|
Differential expression of epigenetic modulators during human embryonic stem cell differentiation.
Molecular Biotechnology.
41:201-207.
2009
|
|
| 2009
|
Strategies targeting telomerase inhibition.
Molecular Biotechnology.
41:194-199.
2009
|
|
| 2009
|
Epigenetic modifications of the estrogen receptor β gene in epithelial ovarian cancer cells.
Anticancer Research.
29:139-144.
2009
|
|
| 2009
|
Regulation of Thy-1 Expression by Histone Modifications in Lung Fibroblast..
American Journal of Respiratory and Critical Care Medicine.
179.
2009
|
|
| 2008
|
Thy-1 promoter hypermethylation: A novel epigenetic pathogenic mechanism in pulmonary fibrosis.
American Journal of Respiratory Cell and Molecular Biology.
39:610-618.
2008
|
|
| 2008
|
EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase.
Biochemical and Biophysical Research Communications.
375:162-167.
2008
|
|
| 2008
|
Gene-environment interactions and epigenetic basis of human diseases.
Current Issues in Molecular Biology.
10:25-36.
2008
|
|
| 2008
|
Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.
International Journal of Oncology.
32:625-631.
2008
|
|
| 2008
|
An overview of epigenetic assays.
Molecular Biotechnology.
38:179-183.
2008
|
|
| 2008
|
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Journal of Cellular Biochemistry.
103:509-519.
2008
|
|
| 2008
|
The novel retinoid, 9cUAB30, inhibits telomerase and induces apoptosis in HL60 cells.
Translational Oncology.
1:148-152.
2008
|
|
| 2007
|
A method to detect DNA methyltransferase I gene transcription in vitro in aging systems.
Methods in Molecular Biology.
371:73-80.
2007
|
|
| 2007
|
A method to study the expression of DNA methyltransferases in aging systems in vitro.
Methods in Molecular Biology.
371:81-87.
2007
|
|
| 2007
|
Aging cell culture: Methods and observations.
Methods in Molecular Biology.
371:9-19.
2007
|
|
| 2007
|
Techniques for analysis of biological aging.
Methods in Molecular Biology.
371:1-7.
2007
|
|
| 2007
|
The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.
International Journal of Oncology.
30:641-650.
2007
|
|
| 2007
|
Evidence of extra-telomeric effects of hTERT and its regulation involving a feedback loop.
Experimental Cell Research.
313:322-330.
2007
|
|
| 2007
|
Methods of telomerase inhibition..
Methods in Molecular Biology.
405:1-7.
2007
|
|
| 2007
|
RNA interference using a plasmid construct expressing short-hairpin RNA..
Methods in Molecular Biology.
405:31-37.
2007
|
|
| 2007
|
Retrovirus-mediated RNA interference. Targeting hTERT through stable expression of short-hairpin RNA..
Methods in Molecular Biology.
405:39-46.
2007
|
|
| 2007
|
hTERT knockdown in human embryonic kidney cells using double-stranded RNA..
Methods in Molecular Biology.
405:23-29.
2007
|
|
| 2006
|
Telomerase inhibition in cancer therapeutics: Molecular-based approaches.
Current Medicinal Chemistry.
13:2875-2888.
2006
|
|
| 2006
|
Integrins and cancer: Gene expression, epigenetics and metastasis.
Current Genomics.
7:323-331.
2006
|
|
| 2006
|
Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.
Oncogene.
25:4370-4375.
2006
|
|
| 2005
|
The epigenetics of breast carcinogenesis and metastasis.
Current Genomics.
6:129-135.
2005
|
|
| 2005
|
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems.
Frontiers in Bioscience.
10:1779-1796.
2005
|
|
| 2005
|
The impact of metabolism on DNA methylation.
Human Molecular Genetics.
14.
2005
|
|
| 2005
|
Increased thymocyte proliferative response to IL-7 and IL-2 at young age is associated with rapid age-related thymic involution in BXD mice.
Federation proceedings.
19:A29-A29.
2005
|
|
| 2004
|
Novel approaches for RNA interference and their application in cancer therapy.
Current Pharmacogenomics.
2:313-324.
2004
|
|
| 2004
|
Genetic and epigenetic modulation of telomerase activity in development and disease.
Gene.
340:1-10.
2004
|
|
| 2004
|
Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation.
Genes, Chromosomes and Cancer.
41:26-37.
2004
|
|
| 2004
|
Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation.
Molecular Cancer Therapeutics.
3:1003-1009.
2004
|
|
| 2004
|
EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis..
International Journal of Oncology.
24:703-710.
2004
|
|
| 2004
|
Methods of epigenetic analysis..
Methods in Molecular Biology.
287:1-8.
2004
|
|
| 2004
|
Profiling DNA methylation by bisulfite genomic sequencing: problems and solutions..
Methods in Molecular Biology.
287:169-179.
2004
|
|
| 2003
|
Telomerase, Telomerase Inhibition, and Cancer.
Journal of Antiaging Medicine.
6:315-325.
2003
|
|
| 2003
|
Epigenetic control of hTERT expression and telomerase activity in differentiating leukemia HL60 cells..
American Journal of Human Genetics.
73:336-336.
2003
|
|
| 2003
|
Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements.
Gene.
316:57-65.
2003
|
|
| 2003
|
Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.
Enzymologia.
252:33-43.
2003
|
|
| 2003
|
Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells.
Biochemical and Biophysical Research Communications.
306:650-659.
2003
|
|
| 2003
|
Analysis of telomerase activity and detection of its catalytic subunit, hTERT.
Analytical Biochemistry.
315:1-21.
2003
|
|
| 2003
|
Assessment of telomere length and factors that contribute to its stability.
European Journal of Biochemistry.
270:389-403.
2003
|
|
| 2003
|
Aging, cancer and nutrition: The DNA methylation connection.
Mechanisms of Ageing and Development.
124:989-998.
2003
|
|
| 2003
|
Telomeres, telomerase, and telomerase inhibition: Clinical implications for cancer.
Journal of the American Geriatrics Society.
51:116-122.
2003
|
|
| 2002
|
Control of telomerase gene expression in differentiating human teratocarcinoma cells.
Gerontologist.
42:3-4.
2002
|
|
| 2002
|
Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts.
Journal of Cellular Biochemistry.
84:324-334.
2002
|
|
| 2001
|
Telomeres and telomerase: Basic science implications for aging.
Journal of the American Geriatrics Society.
49:1105-1109.
2001
|
|
| 2001
|
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).
Gene.
269:1-12.
2001
|
|
| 2001
|
Correlation of hTERT expression with in vitro morphological changes in senescent and retinoic acid-treated cells-acid-treated.
Federation proceedings.
15:A1101-A1101.
2001
|
|
| 2001
|
Mechanisms for telomerase gene control in aging cells and tumorigenesis.
Medical Hypotheses.
56:630-637.
2001
|
|
| 1998
|
Analysis in Escherichia coli of the effects of in vivo CpG methylation catalyzed by the cloned murine maintenance methyltransferase.
Biochemical and Biophysical Research Communications.
245:670-678.
1998
|
|
| 1997
|
Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase.
Journal of Molecular Biology.
269:494-504.
1997
|
|
| 1995
|
Mammalian DNA (cytosine-5-)-methyltransferase expressed in Escherichia coli, purified and characterized.
Journal of Biological Chemistry.
270:18543-18550.
1995
|
|
| 1994
|
Molecular resurrection of an extinct ancestral promoter for mouse L1.
Proceedings of the National Academy of Sciences.
91:1569-1573.
1994
|
|
| 1993
|
Mechanisms for methylation-mediated gene silencing and aging.
Medical Hypotheses.
41:83-92.
1993
|
|
| 1990
|
The protein synthetic surge in response to mitogen triggers high glycolytic enzyme levels in human lymphocytes and occurs prior to DNA synthesis.
Biochemical medicine and metabolic biology.
44:282-291.
1990
|
|
| 1987
|
The effects of aging on phosphofructokinase induction during lymphocyte mitogenesis in relation to DNA and protein synthesis..
Enzymologia.
75:113-122.
1987
|
|
| 1987
|
Gene expression of carbohydrate metabolism in cellular senescence and aging..
Molecular biology & medicine.
4:251-263.
1987
|
|
| 1986
|
Expression of intracellular biochemical defects of lymphocytes in aging: Proposal of a general aging mechanism which is not cell-specific.
Experimental Gerontology.
21:129-148.
1986
|
|
| 1986
|
Role of Protein Molecular and Metabolic Aberrations in Aging, in the Physiologic Decline of the Aged, and in Age‐Associated Diseases.
Journal of the American Geriatrics Society.
34:282-294.
1986
|
|
| 1985
|
Carbohydrate metabolism in transforming lymphocytes from the aged.
Journal of Cellular Physiology.
123:417-424.
1985
|
|
| 1985
|
Culture kinetics of glycolytic enzyme induction, glucose utilization, and thymidine incorporation of extended‐exposure phytohemagglutinin‐stimulated human lymphocytes.
Journal of Cellular Physiology.
122:98-104.
1985
|
|
| 1985
|
Decreased protein synthesis of transforming lymphocytes from aged humans: Relationship to impaired mitogenesis with age.
Mechanisms of Ageing and Development.
30:53-62.
1985
|
|
| 1985
|
Molecular basis of the accumulation of abnormal proteins in progeria and aging fibroblasts..
Basic Life Sciences.
35:427-442.
1985
|
|
| 1984
|
Werner's syndrome: An underdiagnosed disorder resembling premature aging.
AGE.
7:75-88.
1984
|
|
| 1984
|
The effect of age on the accumulation of labile triosephosphate isomerase and thymidine incorporation in pokeweed mitogen stimulated human lymphocytes.
Journal of Gerontology.
39:398-405.
1984
|
|
| 1982
|
Increased lability of triosephosphate isomerase in progeria and Werner's syndrome fibroblasts.
Mechanisms of Ageing and Development.
20:93-101.
1982
|
|
| 1981
|
Impaired glycolysis of human lymphocytes during aging.
Mechanisms of Ageing and Development.
17:369-379.
1981
|
|
| 1980
|
Proteolytic modification of human phosphoglycerate kinase from lymphoblasts.
Archives of Biochemistry and Biophysics.
205:280-282.
1980
|
|
